Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.25%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +35.58%
#5 Humanity Humanity +26.67%
#6 Codatta Codatta +18.76%
#7 Walrus Walrus +18.15%
#8 Enso Enso +18.11%
#9 The Black Bull The Black Bull +14.64%
#10 Collector Crypt Collector Crypt +14.30%
Coin of the day
EXOD EXOD
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Accustem Sciences Inc. Accustem Sciences Inc.

Accustem Sciences Inc.

ACUT
Rang in Aktien #36602
AccuStem Sciences, Inc. operates as a life science firm committed to improving... AccuStem Sciences, Inc. operates as a life science firm committed to improving the outlook for individuals battling cancer. Its primary innovation is the StemPrintER technology, an advanced multi-gene prognostic assay designed to predict the likelihood of recurrence for patients with Endocrine receptor-positive /HER2- breast cancer. The company also offers Spare, a related diagnostic tool that expands upon StemPrintER by incorporating two additional clinical markers. AccuStem Sciences, Inc. is based in New York, New York.
Aktienkurs
$0.156
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$2.51M
Veränderung (1 Tag)
2.97%
Veränderung (1 Jahr)
-91.28%
Land
US
Handel Accustem Sciences Inc. (ACUT)

Kategorie

Healthcare
Aktien-Split-Historie für Accustem Sciences Inc. (ACUT)
Die Aktie Accustem Sciences Inc. (Symbol: ACUT) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 15, 2026 statt.
Eine ACUT-Aktie, die vor dem Aug 15, 2026 gekauft wurde, entspricht heute 0 ACUT-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE